May 10, 2024 Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
Feb 21, 2024 Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Feb 14, 2024 Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Feb 7, 2024 Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
Nov 14, 2023 Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
Nov 13, 2023 Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
Nov 6, 2023 Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
Oct 10, 2023 Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology